From DCAT Value Chain Insights (VCI)
The British Generic Manufacturers Association (BGMA) has launched a new forum in conjunction with UK's regulatory authority, the Medicines and Healthcare Products Regulatory Agency (MHRA). to focus on ensuring the manufacturing quality of generic medicines in the UK.
The new group will meet three times a year to share and discuss the latest issues that impact on the quality of generic medicines. The forum will bring together generic medicines companies, those who provide manufacturing and quality control services, as well as the MHRA. Topics to be covered will include current MHRA approaches to inspection, trends, and the auditing that companies perform themselves.
In a statement, BGMA’s Technical Director Paul Fleming said: "As regulatory requirements and supply chains become ever more complex, supporting high quality standards is vitally important for the pharmaceutical industry, patients and the value we deliver to the NHS. From a generic medicines perspective, we wanted to launch something that was closely aligned with the regulator in order to increase mutual understanding as well as share the latest information quickly and easily."
Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT).
Learn more and sign up to receive a complimentary subscription